FDA Seizes Glaxo’s Paxil, Avandamet

The U.S. Food and Drug Administration said on Friday that officials had seized batches of GlaxoSmithKline Plc’s diabetes drug Avandamet and the controlled-release antidepressant Paxil CR because of concerns over manufacturing quality.

The FDA said in a statement that the manufacturing practices for the two drugs failed to meet standards for safety, strength, quality and purity. However, the agency said it was not aware of any harm to consumers and did not believe there was a significant health hazard.

Patients taking the two drugs were advised to continue taking their medication but talk to their doctor about possibly using alternative products until the manufacturing problems have been corrected.

Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.

Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).

Comments

This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.

Trackbacks

    Last reviewed: By John M. Grohol, Psy.D. on 7 Mar 2005
    Published on PsychCentral.com. All rights reserved.